University of Düsseldorf, Medical Faculty, Department of Neurology, Germany.
Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Università della Svizzera italiana (USI), Faculty of Biomedical Sciences, Institute for Research in Biomedicine, Bellinzona, Switzerland.
Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Sanofi-Aventis Germany, Frankfurt Am Main, Germany.
Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden / KTH – Royal Institute of Technology, Stockholm, Sweden.
Innsbruck Medical University, Innsbruck, Austria.
Department of Neurology, Technische Universität München, Munich, Germany.
Department of Neurology, Technische Universität München, Munich, Germany.
Merck NBE Bioanalytics Ivrea, Colleretto Giacosa, Italy.
Hospital Universitari Vall d'Hebron, Centre d'Esclerosi Múltiple de Catalunya, Barcelona, Spain.
Hospital Regional Universitario de Málaga, Instituto de investigación Biomédica de Málaga (IBIMA), Universidad de Málaga, Spain.
MS Center, Department of Neurology and Center Clinical Neuroscience, Charles University in Prague, 1st Faculty of Medicine and General University Hospital, Prague, Czech Republic.
Department of Neurology, Medical University of Graz, Austria.
Clinic for Neurology 2, Kepler University Clinic, Med Campus III, Linz, Austria.
Clinic for Neurology 2, Kepler University Clinic, Med Campus III, Linz, Austria.
Departments of Biomedicine and Neurology, University Hospital Basel and University of Basel, Switzerland.
Departments of Biomedicine and Neurology, University Hospital Basel and University of Basel, Switzerland.
CESP, INSERM UMR 1018, Faculty of Medicine, Paris-Sud University, Paris-Saclay, University UVSQ, Villejuif, France.
CESP, INSERM UMR 1018, Faculty of Medicine, Paris-Sud University, Paris-Saclay, University UVSQ, Villejuif, France.
University of Düsseldorf, Medical Faculty, Department of Neurology, Germany.
Ipsen Biopharm Ltd., Berkshire, United Kingdom.
GlaxoSmithKline R&D, Uxbridge, Middlesex, United Kingdom.
Department of Neurology, Technische Universität München, Germany / Munich Cluster for systems Neurology (SyNergy), Germany.
MS Center, Department of Neurology and Center Clinical Neuroscience, Charles University in Prague, 1st Faculty of Medicine and General University Hospital, Prague, Czech Republic.
University of Düsseldorf, Medical Faculty, Department of Neurology, Germany.
University of Düsseldorf, Medical Faculty, Department of Neurology, Germany.
Hospital Universitari Vall d'Hebron, Centre d'Esclerosi Múltiple de Catalunya, Barcelona, Spain.
Hospital Universitari Vall d'Hebron, Centre d'Esclerosi Múltiple de Catalunya, Barcelona, Spain.
Departments of Biomedicine and Neurology, University Hospital Basel and University of Basel, Switzerland.
Danish Multiple Sclerosis Center, Department of Neurology, Rigshospitalet, University of Copenhagen, Denmark.
INSERM UMR 996, Univ. Paris-Sud, Faculty of Pharmacy, Université Paris-Saclay, Châtenay-Malabry, France.
Drug Metabolism Pharmacokinetics-Biologics, Novartis Institutes for Biomedical Research, Basel, Switzerland.
CESP, INSERM UMR 1018, Faculty of Medicine, Paris-Sud University, Paris-Saclay, University UVSQ, Villejuif, France / Assistance Publique - Hôpitaux de Paris, Hôpital Paul Brousse, Villejuif, France.
Innsbruck Medical University, Austria.
Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Danish Multiple Sclerosis Center, Department of Neurology, Rigshospitalet, University of Copenhagen, Denmark.
Elsevier, 2019. Vol. 326, p. 19-27
Anti-drug antibodies, Bridging ELISA, Interferon-beta, Luciferase-based bioassay, Multiple sclerosis, Neutralizing antibodies